Accord Gets First EU-Wide Nod For Xarelto Rival

But Originator Bayer Claims Xarelto Patent Protection Until 2023

 
• By David Wallace
Xarelto
Xarelto is a big earner worldwide for Bayer • Source: Shutterstock

More from Generics

More from Products